Appoints Kevin Coop as CEO effective June 24; Founder Krantz remains Executive Chairman

Definitive Healthcare Corp.

Kevin Coop appointed CEO effective June 24, 2024; founder Jason Krantz steps down as interim CEO but stays as Executive Chairman.
Coop receives base salary $500k, target bonus 100%, initial RSU grant of $7.5M value, and performance PSUs with stock price hurdles $10-$27.
At annual meeting, stockholders elected three Class III directors, ratified Deloitte as auditor, and approved say-on-pay on a non-binding basis.
2023 Inducement Plan amended to increase reserved shares to 4.4 million for the inducement grants to Coop.

item 5.02 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin Coop

Chief Executive Officer

DH · Definitive Healthcare Corp.

Effective: 2024-06-24
Filed: May 24, 2024, 7:59 PM ET

On May 20, 2024, the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) appointed Kevin Coop to the position of Chief Executive Officer (“CEO”) and as a member of the Board, each effective June 24, 2024 (the “Start Date”).

Departed (interim)

Jason Krantz

Interim Chief Executive Officer

DH · Definitive Healthcare Corp.

Effective: 2024-06-24
Successor: Kevin Coop
Filed: May 24, 2024, 7:59 PM ET

Effective on the Start Date, Jason Krantz, the Company’s founder, Executive Chairman of the Board and current Interim CEO will step down from his role as Interim CEO and continue to serve as Executive Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin Coop was appointed as Chief Executive Officer at Definitive Healthcare Corp..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On May 20, 2024, the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) appointed Kevin Coop to the position of Chief Executive Officer (“CEO”) and as a member of the Board, each effective June 24, 2024 (the “Start Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Krantz departed as Interim Chief Executive Officer at Definitive Healthcare Corp..

Action: stepped down
Role: Interim Chief Executive Officer

Exact text from the filing

Effective on the Start Date, Jason Krantz, the Company’s founder, Executive Chairman of the Board and current Interim CEO will step down from his role as Interim CEO and continue to serve as Executive Chairman of the Board.

View on SEC.gov

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-24-064571

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.